Increased Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Male Heroin Addicts: A Prospective Controlled Study

키워드

참고문헌 (47)

1. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders", American Psychiatric Association, ~ (2013)
2. World drug report 2010, "United Nations Office on Drugs and Crime", United Nations Publications, ~ (2010)
3. Merikangas KR, "Epidemiology of substance use disorders", Hum Genet, 131, pp.779~789 (2012)[DOI]
4. Sadock BJ, "Kaplan and Sadock's comprehensive textbook of psychiatry. 8th ed." (2007), Gunes Kitabevi
5. Ogel K, "Alkol ve Madde Kullanim bozukluklari: Tani, Tedavi ve Onleme" (2010), Yeniden Yayinlari
6. Mehmet Akif Camkurt, "Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients", Clinical Psychopharmacology and Neuroscience, 14(3), pp.256~260 (2016), 대한정신약물학회
7. Mehmet Akif Camkurt, "Evaluation of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Fetal Cord Blood of Depressed Mothers", Clinical Psychopharmacology and Neuroscience, 15(1), pp.35~39 (2017), 대한정신약물학회[DOI]
8. Rimjhim Agrawal, "In Silico Model-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology", Clinical Psychopharmacology and Neuroscience, 15(2), pp.115~125 (2017), 대한정신약물학회[DOI]
9. Kim YK, "Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder", J Affect Disord, 104, pp.91~95 (2007)[DOI]
10. Brietzke E, "Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder", Brain Behav Immun, 23, pp.1079~1082 (2009)[DOI]
11. Na KS, "The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 48, pp.277~286 (2014)[DOI]
12. Chen SL, "Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment", J Neuroimmune Pharmacol, 7, pp.1025~1033 (2012)[DOI]
13. Pacifici R, "Pharmacokinetics and cytokine production in heroin and morphine-treated mice", Int J Immunopharmacol, 22, pp.603~614 (2000)[DOI]
14. Chan YY, "Inflammatory response in heroin addicts undergoing methadone maintenance treatment", Psychiatry Res, 226, pp.230~234 (2015)[DOI]
15. Sacerdote P, "Opioids and the immune system", Palliat Med, 20(Suppl 1), pp.s9~s15 (2006)
16. Vallejo R, "Opioid therapy and immunosuppression: a review", Am J Ther, 11, pp.354~365 (2004)[DOI]
17. Nelson CJ, "Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation", Brain Behav Immun, 14, pp.170~184 (2000)[DOI]
18. Stefano GB, "Opioid and opiate immunoregulatory processes", Crit Rev Immunol, 16, pp.109~144 (1996)[DOI]
19. Fecho K, "Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats", J Pharmacol Exp Ther, 276, pp.626~636 (1996)
20. McCarthy L, "Opioids, opioid receptors, and the immune response", Drug Alcohol Depend, 62, pp.111~123 (2001)[DOI]
21. Balta S, "The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events", Platelets, 26, pp.680~681 (2015)[DOI]
22. Zahorec R, "Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill", Bratisl Lek Listy, 102, pp.5~14 (2001)
23. Turkmen K, "Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients", Hemodial Int, 17, pp.391~396 (2013)[DOI]
24. Gary T, "Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients", PLoS One, 8, pp.e67688~ (2013)[DOI]
25. Kwon HC, "Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer", Biomarkers, 17, pp.216~222 (2012)[DOI]
26. Bhatti I, "Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophillymphocyte versus platelet-lymphocyte ratio", Am J Surg, 200, pp.197~203 (2010)[DOI]
27. Kuyumcu ME, "The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease", Dement Geriatr Cogn Disord, 34, pp.69~74 (2012)[DOI]
28. Semiz M, "Elevated neutrophil", lymphocyte ratio in patients with schizophrenia, 2014, pp.26, 220~225
29. Kalelioglu T, "Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder", Psychiatry Res, 228, pp.925~927 (2015)[DOI]
30. Demir S, "Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy", Neuropsychiatr Dis Treat, 11, pp.2253~2258 (2015)
31. Demircan F, "The impact of red blood cell distribution width and neutrophil", lymphocyte ratio on the diagnosis of major depressive disorder, 2016, pp.5, 27~33
32. Puppe B, "The effect of housing conditions and social environment immediately after weaning on the agonistic behaviour, neutrophil", lymphocyte ratio, and plasma glucose level in pigs, 1997, pp.48, 157~164
33. Trevisi E, "Some physiological and biochemical methods for acute and chronic stress evaluation in dairy cows", Ital J Anim Sci, 8(Suppl 1), pp.265~286 (2009)[DOI]
34. Turkmen K, "The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients", Ren Fail, 34, pp.1229~1237 (2012)[DOI]
35. First MB, "User's guide for the structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version" (1997), American Psychiatric Press
36. Ozkurkcugil A, "Adaptation and reliability study of Structured Clinical Interview for DSM-IV Axis I disorders", Turk J Drug Ther, 12, pp.233~236 (1999)
37. McLellan AT, "The fifth edition of the Addiction Severity Index", J Subst Abuse Treat, 9, pp.199~213 (1992)[DOI]
38. Demirbas H, "Bagimlilik Siddetini Belirleme Olceginin Gecerlik-Guvenilirlilik calismasi", pp.2003
39. Cakir U, "Increased neutrophil", lymphoctye ratio in patients with bipolar disorder: a preliminary study, 2015, pp.27, 180~184
40. Wang Z, "Immune function alterations during 12 weeks of abstinence in heroin users", Folia Biol (Praha), 61, pp.241~246 (2015)
41. Reece AS, "Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers", Immun Ageing, 4, pp.6~ (2007)[DOI]
42. Koyama H, "Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans", Circulation, 108, pp.524~529 (2003)[DOI]
43. Shoji T, "Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis", Atherosclerosis, 188, pp.190~195 (2006)[DOI]
44. Borissoff JI, "The hemostatic system as a modulator of atherosclerosis", N Engl J Med, 364, pp.1746~1760 (2011)[DOI]
45. Langer HF, "Platelet-vessel wall interactions in atheroscleroticdisease", Thromb Haemost, 99, pp.480~486 (2008)[DOI]
46. Nikolova M, "Clinical significance of antinuclear antibodies, anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies in heroin abusers", Isr Med Assoc J, 4(11 Suppl), pp.908~910 (2002)
47. Piepenbrink MS, "Humoral dysregulation associated with increased systemic inflammation among injection heroin users", PLoS One, 11, pp.e0158641~ (2016)[DOI]

관련 논문AI추천